Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine

Maria Teresa Voso; Emiliano Fabiani; A Piciocchi; C Matteucci; L Brandimarte; C Finelli; E Pogliani; E Angelucci; G Fioritoni; P Musto; Mariangela Greco; Marianna Criscuolo; Luana Fianchi; M Vignetti; V Santini; Stefan Hohaus; C Mecucci; Giuseppe Leone

doi:10.1038/leu.2011.170

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine

Maria Teresa Voso
, Emiliano Fabiani
, A Piciocchi
, C Matteucci
, L Brandimarte
, C Finelli
, E Pogliani
, E Angelucci
, G Fioritoni
, P Musto
, Mariangela Greco
, Marianna Criscuolo
, Luana Fianchi
, M Vignetti
, V Santini
, Stefan Hohaus
, C Mecucci
, Giuseppe Leone

Risultato della ricerca: Contributo in rivista › Articolo › peer review

34 Citazioni (Scopus)

Abstract

No Abtsract

Lingua originale	Inglese
pagine (da-a)	1910-1913
Numero di pagine	4
Rivista	Leukemia
Volume	25
DOI	https://doi.org/10.1038/leu.2011.170
Stato di pubblicazione	Pubblicato - 2011

Keywords

Adult
Aged
Antimetabolites, Antineoplastic
Azacitidine
DNA Methylation
DNA-Binding Proteins
Female
Humans
Male
Middle Aged
Mutation
Myelodysplastic Syndromes
Prognosis
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
Retrospective Studies
Risk Factors
Survival Rate

Accesso al documento

10.1038/leu.2011.170

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Voso, M. T., Fabiani, E., Piciocchi, A., Matteucci, C., Brandimarte, L., Finelli, C., Pogliani, E., Angelucci, E., Fioritoni, G., Musto, P., Greco, M., Criscuolo, M., Fianchi, L., Vignetti, M., Santini, V., Hohaus, S., Mecucci, C., & Leone, G. (2011). Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine. Leukemia, 25, 1910-1913. https://doi.org/10.1038/leu.2011.170

@article{c7de1d7a5155479bbbf88f8b396113bc,

title = "Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine",

abstract = "No Abtsract",

keywords = "Adult, Aged, Antimetabolites, Antineoplastic, Azacitidine, DNA Methylation, DNA-Binding Proteins, Female, Humans, Male, Middle Aged, Mutation, Myelodysplastic Syndromes, Prognosis, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-bcl-2, Retrospective Studies, Risk Factors, Survival Rate, Adult, Aged, Antimetabolites, Antineoplastic, Azacitidine, DNA Methylation, DNA-Binding Proteins, Female, Humans, Male, Middle Aged, Mutation, Myelodysplastic Syndromes, Prognosis, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-bcl-2, Retrospective Studies, Risk Factors, Survival Rate",

author = "Voso, \{Maria Teresa\} and Emiliano Fabiani and A Piciocchi and C Matteucci and L Brandimarte and C Finelli and E Pogliani and E Angelucci and G Fioritoni and P Musto and Mariangela Greco and Marianna Criscuolo and Luana Fianchi and M Vignetti and V Santini and Stefan Hohaus and C Mecucci and Giuseppe Leone",

year = "2011",

doi = "10.1038/leu.2011.170",

language = "English",

volume = "25",

pages = "1910--1913",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

}

Voso, MT, Fabiani, E, Piciocchi, A, Matteucci, C, Brandimarte, L, Finelli, C, Pogliani, E, Angelucci, E, Fioritoni, G, Musto, P, Greco, M, Criscuolo, M, Fianchi, L, Vignetti, M, Santini, V, Hohaus, S, Mecucci, C & Leone, G 2011, 'Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine', Leukemia, vol. 25, pagg. 1910-1913. https://doi.org/10.1038/leu.2011.170

TY - JOUR

T1 - Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine

AU - Voso, Maria Teresa

AU - Fabiani, Emiliano

AU - Piciocchi, A

AU - Matteucci, C

AU - Brandimarte, L

AU - Finelli, C

AU - Pogliani, E

AU - Angelucci, E

AU - Fioritoni, G

AU - Musto, P

AU - Greco, Mariangela

AU - Criscuolo, Marianna

AU - Fianchi, Luana

AU - Vignetti, M

AU - Santini, V

AU - Hohaus, Stefan

AU - Mecucci, C

AU - Leone, Giuseppe

PY - 2011

Y1 - 2011

N2 - No Abtsract

AB - No Abtsract

KW - Adult

KW - Aged

KW - Antimetabolites, Antineoplastic

KW - Azacitidine

KW - DNA Methylation

KW - DNA-Binding Proteins

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Mutation

KW - Myelodysplastic Syndromes

KW - Prognosis

KW - Proto-Oncogene Proteins

KW - Proto-Oncogene Proteins c-bcl-2

KW - Retrospective Studies

KW - Risk Factors

KW - Survival Rate

KW - Adult

KW - Aged

KW - Antimetabolites, Antineoplastic

KW - Azacitidine

KW - DNA Methylation

KW - DNA-Binding Proteins

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Mutation

KW - Myelodysplastic Syndromes

KW - Prognosis

KW - Proto-Oncogene Proteins

KW - Proto-Oncogene Proteins c-bcl-2

KW - Retrospective Studies

KW - Risk Factors

KW - Survival Rate

UR - http://hdl.handle.net/10807/2086

U2 - 10.1038/leu.2011.170

DO - 10.1038/leu.2011.170

M3 - Article

SN - 0887-6924

VL - 25

SP - 1910

EP - 1913

JO - Leukemia

JF - Leukemia

ER -

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo